89 related articles for article (PubMed ID: 2182341)
1. Immunohistochemical study of the ras oncogene expression in human bladder endoscopy specimens.
Agnantis NJ; Constantinidou A; Poulios C; Pintzas A; Kakkanas A; Spandidos DA
Eur J Surg Oncol; 1990 Apr; 16(2):153-60. PubMed ID: 2182341
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
3. H-ras immunohistochemical expression and molecular analysis of urinary bladder lesions in grazing adult cattle exposed to bracken fern.
Sardon D; de la Fuente I; Calonge E; Perez-Alenza MD; Castaño M; Dunner S; Peña L
J Comp Pathol; 2005; 132(2-3):195-201. PubMed ID: 15737346
[TBL] [Abstract][Full Text] [Related]
4. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the expression of the P21 ras oncogene product and the biological behavior of bladder tumors.
Miao TJ; Wang Z; Sang N
Eur Urol; 1991; 20(4):307-10. PubMed ID: 1814747
[TBL] [Abstract][Full Text] [Related]
6. [Oncogene ras P 21 expression and DNA ploidy in human bladder tumor].
Wang Z
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):245-8. PubMed ID: 1806342
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical demonstration of p21ras in normal and transitional cell carcinoma urothelium.
Dunn TL; Seymour GJ; Gardiner RA; Strutton GM; Lavin MF
J Pathol; 1988 Sep; 156(1):59-65. PubMed ID: 3057152
[TBL] [Abstract][Full Text] [Related]
8. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
King ED; Matteson J; Jacobs SC; Kyprianou N
J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
[TBL] [Abstract][Full Text] [Related]
9. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Yaginuma Y; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
12. ras induced lesions in a heterotopic mouse bladder.
Wagner HE; Joyce AD; Beatrice K; Summerhayes IC
Oncogene; 1990 Apr; 5(4):557-63. PubMed ID: 2183157
[TBL] [Abstract][Full Text] [Related]
13. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
14. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
[TBL] [Abstract][Full Text] [Related]
17. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
Tong GX; Yee H; Chiriboga L; Hernandez O; Waisman J
Hum Pathol; 2005 Jul; 36(7):741-6. PubMed ID: 16084942
[TBL] [Abstract][Full Text] [Related]
18. [Cytokeratins and transitional epithelium of the bladder. Particular distribution of cytokeratins].
Fetissof F; Serres G; Haillot O
Arch Anat Cytol Pathol; 1990; 38(4):159-62. PubMed ID: 1699500
[TBL] [Abstract][Full Text] [Related]
19. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
